Skip to content
Home India Ministry of Chemicals and Fertilizers : Department of Pharmaceuticals Notifications India's medical device industry projected to reach... (Official PDF)
Date: 7th August 2026 Category: Press Release Jurisdiction: India, Central Government

India's medical device industry projected to reach $250 billion by - 7th August 2026 - Ministry of Chemicals and Fertilizers : Department of Pharmaceuticals - Gazette Notification PDF

Issued by Ministry of Chemicals and Fertilizers : Department of Pharmaceuticals

Read or download the official PDF of this gazette notification issued by the Ministry of Chemicals and Fertilizers : Department of Pharmaceuticals on 7th August 2026. Classified under Press Release.

Executive Summary & Key Takeaways

Executive Summary The FICCI-DUA Consulting White Paper, released during the "India Medical Device 2026" session on August 7, 2026, projects India’s medical device industry will reach $250 billion by 2047. The document emphasizes that sustained growth requires a transition from a manufacturing-only focus to a comprehensive ecosystem for servicing, maintenance, and lifecycle management. Key recommendations include the implementation of a risk-tiered maintenance framework and a national certification architecture for service engineers.

Key Points / Main Content

Market Projections and Growth Drivers

  • The sector is currently valued at $14 billion, with projections of $30–50 billion within the decade and $250 billion by 2047.
  • Growth is fueled by rising healthcare demand, adoption of advanced technologies, and government support through initiatives like the Production Linked Incentive (PLI) Scheme.
  • India aims to become a global MedTech hub through indigenous manufacturing and improved global competitiveness.

The Critical Role of Equipment Maintenance

  • Medical equipment serves as the backbone of modern healthcare, supporting diagnosis, surgeries, and emergency responses.
  • The value of medical technology extends beyond procurement to reliable servicing throughout its operational lifecycle.
  • Proper maintenance is essential for improving patient safety, enhancing clinical effectiveness, and optimizing healthcare investments by extending equipment life.

Proposed Regulatory and Operational Frameworks

  • Risk-Tiered Framework: A proposed maintenance system anchored in the Central Drugs Standard Control Organisation (CDSCO) device classification.
  • National Standards: Recommendation for a national certification architecture for service engineers and strengthened technical training.
  • Fiscal and Commercial Reform: A call to rationalise fiscal frameworks to promote compliant maintenance and encourage commercial model innovation.
  • Digital Integration: Advocacy for digital technologies, including predictive maintenance and digital monitoring, to minimize equipment downtime.

Impact Analysis

Government and Regulatory Bodies (Department of Pharmaceuticals/CDSCO) Impact Responsible for the oversight and implementation of the proposed national maintenance standards and fiscal rationalization. Action Required Establish maintenance protocols based on device risk categories and create a national certification architecture for technical personnel.

Medical Device Manufacturers and Service Providers Impact Shift in focus from purely manufacturing and sales to long-term lifecycle management and servicing. Action Required Invest in technical training for service engineers and adopt digital monitoring and predictive maintenance systems.

Healthcare Providers and Hospitals Impact Affected by the reliability of equipment and the quality of clinical outcomes linked to equipment uptime. Action Required Implement the proposed risk-tiered maintenance protocols to ensure patient safety and optimize the lifespan of medical assets.

Key Entities Referenced

FICCI-DUA Consulting White Paper: A report titled ‘Service and Maintenance of Medical Equipment in Indian Healthcare’ that proposes a roadmap for a sustainable medical device maintenance ecosystem. Central Drugs Standard Control Organisation (CDSCO): The regulatory body whose device classification system is proposed as the foundation for a new risk-tiered hybrid maintenance framework. Production Linked Incentive (PLI) Scheme: A major government initiative designed to enhance domestic manufacturing capabilities and global competitiveness in the medical device sector. Strengthening of Medical Devices Industry Scheme: A key initiative aimed at improving domestic manufacturing and the global standing of India's medical device industry. Department of Pharmaceuticals: The primary government department responsible for organizing 'India Medical Device 2026' and overseeing the sector's development.
Official Gazette PDF Record Download Official PDF (India's medical device industry projected...) →

Official Gazette Notification PDF Viewer

See Full Document Text & PDF Transcript
Ministry of Chemicals and Fertilizers : Department of Pharmaceuticals India's medical device industry projected to reach $250 billion by 2047: FICCI-DUA Consulting Report प्रव तथ: 07 AUG 2026 4:44PM by PIB Delhi India's medical device industry is expected to emerge as a global powerhouse with a projected market size of $250 billion by 2047, according to FICCI-DUA Consulting White Paper on ‘Service and Maintenance of Medical Equipment in Indian Healthcare – Towards a Safe, Reliable and Sustainable Medical Device Maintenance Ecosystem’ The White Paper released during the inaugural session of the 9th edition of ‘India Medical Device 2026’, organised by the Department of Pharmaceuticals in association with FICCI here today says that India's medical device sector, currently valued at around $14 billion, is projected to reach $30-50 billion within this decade, and likely to reach $250 billion by 2047. It says rising healthcare demand, increased adoption of advanced medical technologies, government support for indigenous manufacturing, and the country's ambition to become a global MedTech hub likely to drive the rapid growth. According to the White Paper, India has made significant progress through initiatives such as the Production Linked Incentive (PLI) Scheme and the Strengthening of Medical Devices Industry Scheme, which have enhanced domestic manufacturing capabilities and improved India's global competitiveness. However, the report stresses that sustained growth of the sector will depend not only on manufacturing but also on creating a world-class ecosystem for servicing, maintenance, calibration and lifecycle management of medical equipment. The report highlights that medical equipment today forms the backbone of modern healthcare, supporting timely diagnosis, emergency response, surgeries and advanced treatment. It argues that the value of these technologies extends well beyond procurement and depends on reliable servicing throughout their operational lifecycle. Proper maintenance, the report says, improves patient safety, enhances clinical effectiveness, reduces equipment downtime, extends equipment life and optimises healthcare investments. To address these issues, the White Paper proposes a risk-tiered hybrid maintenance framework anchored in the Central Drugs Standard Control Organisation (CDSCO) device classification system. It recommends maintenance protocols based on device risk categories, creation of a national certification architecture for service engineers, strengthening technical training, encouraging commercial model innovation, and rationalising the fiscal framework to promote compliant maintenance practices. The report also advocates wider adoption of digital technologies, including predictive maintenance, digital monitoring and lifecycle management systems, to improve equipment reliability and minimise downtime. The report presents a comprehensive roadmap for creating a safe, transparent and sustainable medical equipment maintenance ecosystem. ***** PC/PM(रलीज़ आईडी: 2296077) आगंतुक पटल : 731 इस वज्ञ को इन भाषाओ ंम पढ़: Urdu , ही , Gujarati , Tamil

Continue your research